Oragenics (OGEN) Cash from Operations (2010 - 2026)
Oragenics' (OGEN) quarterly Cash from Operations came in at 2200644.0 in Q1 2026, down 4.19% YoY from 2296948.6 in Q1 2025, and up 21.41% on a QoQ basis from 2800000.0 in Q4 2025.
Oragenics (OGEN) Cash from Operations (2010 - 2026) Analysis & Trends
Oragenics (OGEN) has 17 years of Cash from Operations data on file, last reported at 2200644.0 in Q1 2026.
- Quarterly Cash from Operations fell 4.19% year-over-year to 2200644.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9288554.0 (down 21.49% YoY) and the FY2025 annual result came in at 9200000.0, down 7.01% from the prior year.
- Cash from Operations improved to 2200644.0 in Q1 2026, from 2800000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1102545.0 in Q4 2023 to a low of 5636952.0 in Q1 2022.
- A 5-year average of 2501022.88 and a median of 2200644.0 in 2026 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations soared 62.59% — and 2024, when it sank 83.06%.
- Tracing OGEN's Cash from Operations over 5 years: stood at 2432836.0 in 2022, then jumped by 54.68% to 1102545.0 in 2023, then slumped by 83.06% to 2018353.0 in 2024, then slumped by 38.73% to 2800000.0 in 2025, then rose by 21.41% to 2200644.0 in 2026.
- The last three Cash from Operations figures came in at 2200644.0 (Q1 2026), 2800000.0 (Q4 2025), and 3000000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 728.46 Mn |
| 10 | Oragenics | 2.32 Mn | 2.32 Mn | - | -2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.20 Mn |
| Jun 30, 2026 | -2.20 Mn |
| Mar 31, 2026 | -2.20 Mn |
| Mar 31, 2026 | -2.20 Mn |
| Dec 31, 2025 | -2.80 Mn |
| Dec 31, 2025 | -2.80 Mn |
| Sep 30, 2025 | -3.00 Mn |
| Sep 30, 2025 | -3.00 Mn |
| Jun 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | -1.29 Mn |
| Mar 31, 2025 | -2.11 Mn |
| Mar 31, 2025 | -2.11 Mn |
| Dec 31, 2024 | -2.02 Mn |
| Dec 31, 2024 | -2.02 Mn |
| Sep 30, 2024 | -1.97 Mn |
| Sep 30, 2024 | -1.97 Mn |
| Jun 30, 2024 | -1.54 Mn |
| Jun 30, 2024 | -1.54 Mn |
| Mar 31, 2024 | -3.06 Mn |
| Mar 31, 2024 | -3.06 Mn |